KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to -$2.1 million.

  • Encompass Health's Deferred Taxes changed 0.0% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 3258.43%. This contributed to the annual value of $10.7 million for FY2024, which is 17435.9% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Deferred Taxes is -$2.1 million, which was down 0.0% from -$3.5 million recorded in Q2 2025.
  • Over the past 5 years, Encompass Health's Deferred Taxes peaked at $35.6 million during Q4 2022, and registered a low of -$8.8 million during Q2 2022.
  • Moreover, its 5-year median value for Deferred Taxes was -$1.2 million (2022), whereas its average is $3.3 million.
  • Per our database at Business Quant, Encompass Health's Deferred Taxes skyrocketed by 52142.86% in 2021 and then plummeted by 25200.0% in 2022.
  • Over the past 5 years, Encompass Health's Deferred Taxes (Quarter) stood at $15.8 million in 2021, then soared by 125.32% to $35.6 million in 2022, then crashed by 80.9% to $6.8 million in 2023, then rose by 26.47% to $8.6 million in 2024, then plummeted by 124.42% to -$2.1 million in 2025.
  • Its Deferred Taxes was -$2.1 million in Q3 2025, compared to -$3.5 million in Q2 2025 and $8.8 million in Q1 2025.